110 related articles for article (PubMed ID: 15918522)
1. Enhanced bioavailability of paclitaxel by bamboo concentrate administration.
Kang KW; Choi JS
Arch Pharm Res; 2005 Apr; 28(4):469-75. PubMed ID: 15918522
[TBL] [Abstract][Full Text] [Related]
2. P-glycoprotein and cytochrome P450 3A act together in restricting the oral bioavailability of paclitaxel.
Hendrikx JJ; Lagas JS; Rosing H; Schellens JH; Beijnen JH; Schinkel AH
Int J Cancer; 2013 May; 132(10):2439-47. PubMed ID: 23090875
[TBL] [Abstract][Full Text] [Related]
3. Effects of silibinin, inhibitor of CYP3A4 and P-glycoprotein in vitro, on the pharmacokinetics of paclitaxel after oral and intravenous administration in rats.
Lee CK; Choi JS
Pharmacology; 2010; 85(6):350-6. PubMed ID: 20523105
[TBL] [Abstract][Full Text] [Related]
4. Effect of genistein on the pharmacokinetics of paclitaxel administered orally or intravenously in rats.
Li X; Choi JS
Int J Pharm; 2007 Jun; 337(1-2):188-93. PubMed ID: 17267149
[TBL] [Abstract][Full Text] [Related]
5. Altered pharmacokinetics of paclitaxel by the concomitant use of morin in rats.
Choi BC; Choi JS; Han HK
Int J Pharm; 2006 Oct; 323(1-2):81-5. PubMed ID: 16806758
[TBL] [Abstract][Full Text] [Related]
6. Enhanced paclitaxel bioavailability after oral administration of paclitaxel or prodrug to rats pretreated with quercetin.
Choi JS; Jo BW; Kim YC
Eur J Pharm Biopharm; 2004 Mar; 57(2):313-8. PubMed ID: 15018990
[TBL] [Abstract][Full Text] [Related]
7. P-glycoprotein inhibition by the multidrug resistance-reversing agent MS-209 enhances bioavailability and antitumor efficacy of orally administered paclitaxel.
Kimura Y; Aoki J; Kohno M; Ooka H; Tsuruo T; Nakanishi O
Cancer Chemother Pharmacol; 2002 Apr; 49(4):322-8. PubMed ID: 11914912
[TBL] [Abstract][Full Text] [Related]
8. Effects of silymarin and formulation on the oral bioavailability of paclitaxel in rats.
Park JH; Park JH; Hur HJ; Woo JS; Lee HJ
Eur J Pharm Sci; 2012 Feb; 45(3):296-301. PubMed ID: 22172604
[TBL] [Abstract][Full Text] [Related]
9. Curcumin enhances oral bioavailability and anti-tumor therapeutic efficacy of paclitaxel upon administration in nanoemulsion formulation.
Ganta S; Devalapally H; Amiji M
J Pharm Sci; 2010 Nov; 99(11):4630-41. PubMed ID: 20845461
[TBL] [Abstract][Full Text] [Related]
10. Effects of cysteine on the pharmacokinetics of paclitaxel in rats.
Lee YK; Han SY; Chin YW; Choi YH
Arch Pharm Res; 2012 Mar; 35(3):509-16. PubMed ID: 22477198
[TBL] [Abstract][Full Text] [Related]
11. Enhanced oral paclitaxel bioavailability after administration of paclitaxel-loaded nanosponges.
Torne SJ; Ansari KA; Vavia PR; Trotta F; Cavalli R
Drug Deliv; 2010 Aug; 17(6):419-25. PubMed ID: 20429848
[TBL] [Abstract][Full Text] [Related]
12. Enhanced bioavailability of paclitaxel after oral coadministration with flavone in rats.
Choi JS; Choi HK; Shin SC
Int J Pharm; 2004 May; 275(1-2):165-70. PubMed ID: 15081147
[TBL] [Abstract][Full Text] [Related]
13. Enhanced paclitaxel bioavailability after oral coadministration of paclitaxel prodrug with naringin to rats.
Choi JS; Shin SC
Int J Pharm; 2005 Mar; 292(1-2):149-56. PubMed ID: 15725561
[TBL] [Abstract][Full Text] [Related]
14. Enhanced oral paclitaxel absorption with vitamin E-TPGS: effect on solubility and permeability in vitro, in situ and in vivo.
Varma MV; Panchagnula R
Eur J Pharm Sci; 2005; 25(4-5):445-53. PubMed ID: 15890503
[TBL] [Abstract][Full Text] [Related]
15. Enhanced oral bioavailability and anti-tumour effect of paclitaxel by 20(s)-ginsenoside Rg3 in vivo.
Yang LQ; Wang B; Gan H; Fu ST; Zhu XX; Wu ZN; Zhan DW; Gu RL; Dou GF; Meng ZY
Biopharm Drug Dispos; 2012 Nov; 33(8):425-36. PubMed ID: 22898996
[TBL] [Abstract][Full Text] [Related]
16. Enhanced oral paclitaxel bioavailability after administration of paclitaxel-loaded lipid nanocapsules.
Peltier S; Oger JM; Lagarce F; Couet W; Benoît JP
Pharm Res; 2006 Jun; 23(6):1243-50. PubMed ID: 16715372
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic synergy from the taxane extract of Taxus chinensis improves the bioavailability of paclitaxel.
Liu Z; Zheng X; Lv J; Zhou X; Wang Q; Wen X; Liu H; Jiang J; Wang L
Phytomedicine; 2015 May; 22(5):573-8. PubMed ID: 25981924
[TBL] [Abstract][Full Text] [Related]
18. Altered oral bioavailability and pharmacokinetics of P-glycoprotein substrates by coadministration of biochanin A.
Peng SX; Ritchie DM; Cousineau M; Danser E; Dewire R; Floden J
J Pharm Sci; 2006 Sep; 95(9):1984-93. PubMed ID: 16850393
[TBL] [Abstract][Full Text] [Related]
19. The effect of verapamil on the pharmacokinetics of paclitaxel in rats.
Choi JS; Li X
Eur J Pharm Sci; 2005 Jan; 24(1):95-100. PubMed ID: 15626582
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of oral bioavailability of paclitaxel after oral administration of Schisandrol B in rats.
Jin J; Bi H; Hu J; Zhong G; Zhao L; Huang Z; Huang M
Biopharm Drug Dispos; 2010 May; 31(4):264-8. PubMed ID: 20437465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
